2012-05-04 · Notice · 2012-10808
Determination of Regulatory Review Period for Purposes of Patent Extension; EGRIFTA
Tesamorelin
Open attributed record →Federal Register publication year
2012 FDA Federal Register peptide records
3 documents attributed to FDA and HHS and published in 2012, connected only through exact reviewed peptide-name matches.
2012-05-02 · Notice · 2012-10517
Determination of Regulatory Review Period for Purposes of Patent Extension; Victoza
Liraglutide
Open attributed record →2012-01-25 · Notice · 2012-1433
Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability
Leuprolide + Octreotide
Open attributed record →